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quartile range [IQR] 19-e62) with a median pressure of 75 (IQR 62e125)
mm Hg. The NWPT system was changed 10 times (SD 9.4) in each patient
yielding 506 microbiological samples. In 55 patients deep wound cultures
could be compared to cultures from the negative pressure wound therapy
foams. Sensitivity, speciﬁcity, PPV and NPV for bacteria retrieved from
negative pressure wound therapy foams compared to deep wound cultures
as gold standard were 67%, 56%, 65%, and 58%, respectively (Table 1).
Conclusion: Antimicrobial therapy should primarily focus on deep
wound cultures, whereas bacteria obtained from NWPT foams seem to be
less important.
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Introduction: The ESCHAR study showed that superﬁcial venous surgery
reduced the recurrence rate compared with compression therapy only.
Ulcer recurrence rates after endovenous laser (EVL) treatment for super-
ﬁcial venous insufﬁciency seem comparable, but so far only small groups
and shorter follow up times have been reported. The aim of this study was
to investigate long term treatment outcomes of patients with venous ulcers
treated with EVL in a larger population, in ordinary clinical practice without
dedicated ulcer care.
Methods: One hundred and ninety seven consecutive patients previ-
ously treated with EVL for a healed or open venous ulcer were invited to
follow up including clinical examination, quality of life score using EQ5D,
Duplex, ankle brachial index, venous reﬁlling time (RT) and pump volume
measured with PPG. Risk factors for non-healing and/or recurrence were
calculated using chi-square to compare proportions and logistic regression.
Results: 197 patients have been examined after a mean follow up time
of 41 months. After EVL further ulcer treatment and compression was
carried out mostly in primary care. Details of post-operative treatment
were not possible to retrieve. 165 patients had healed ulcers (Group 1)
without recurrence during follow up, 32 patients never healed or had a
recurrence after EVL (Group 2). The mean age was 62.7 years for group 1
and 64,2 for group 2 (NS). The number of women/men was 99/66 in group
1 and 14/18 in group 2 (NS). Signiﬁcant risk factors for non-healing and or
recurrence were reduced ankle mobility (p ¼ .009), perforating vein
insufﬁciency (PVI) in the ulcer area (p ¼ .007), popliteal and crural vein
insufﬁciency (p ¼ .016 and .000 respectively) and shortened RT (p ¼ .016).
There was a greater proportion in group 2 with previous deep venous
thrombosis, diabetes, remnant varicose veins (VV) in ulcer area, and they
had lower QoL, but no signiﬁcance was reached. Other non-signiﬁcant risk
factors were cardiovascular disease, previous VV surgery, smoking, C5 or C6
at EVL, skin disease and remnant VV outside ulcer area.
Conclusion: Endovenous laser ablation treating patients with venous
ulcers in ordinary clinical practice confers long-term healing in a majority.
Non-healing and recurrence was associated with reduced ankle mobility,
deep and perforating vein insufﬁciency and shortened RT. It may bespeculated that healing rates can be further improved with a more dedi-
cated ulcer care and follow up post-operatively.
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Introduction: Fenestrated endovascular aneurysm repair (FEVAR) has
revolutionized the management of complex aortic aneurysms; however the
procedure exposes operators and patients to more radiation than con-
ventional open surgery. Three dimensional (3D) fusion computed tomog-
raphy (CT) imaging is a new technology that may reduce radiation and
facilitate faster repair. The primary aim of this study was to evaluate the
radiation dose effect of introducing fusion imaging techniques to an expert
team.
Methods: Procedural details were gathered prospectively for a cohort of
18 consecutive patients receiving fusion-guided (Fusion Group) FEVAR and
compared with 21 patients treated in the immediate 12 months prior to
the implementation of routine fusion imaging (Standard Group) at a centre
with established expertise in FEVAR. Data distributions were found to be
non-Gaussian, so non-parametric tests were used to compare procedure
time (PT), radiation dose, dose-area product (DAP), ﬂuoroscopy time (FT),
estimated blood loss (EBL) and pre- and post-operative estimated
glomerular ﬁltration rate (eGFR) between the groups.
Results: There were 18 and 21 patients in the Fusion and Standard
groups, respectively. The Fusion group received three 2 vessel-, ten 3
vessel-, four 4 vessel-, and one single vessel- fenestrated graft(s). The
Standard group received ﬁve 4 vessel-, eleven 3 vessel-, four 2 vessel-, and
one single-vessel graft(s). There was a signiﬁcant reduction in PT for the
Fusion group (median 285 min; interquartile range 265 e323) compared
with the Standard group (420 min; IQR 330 e310 p ¼ <0.001). There were
signiﬁcant reductions in radiation skin dose for the Fusion group (1.65 Gy;
IQR 1.22e2.22) compared with the Standard group (4.39 Gy; 3.28e7.05
p ¼ <0.001), and DAP; Fusion (173.64 Gy cm22; IQR 138.33 e232.77) vs.
(264.93 Gy cm22; 173.37e366.85) for Standard (p ¼ 0.001). Estimated
blood loss was signiﬁcantly reduced for Fusion (350 ml; 250e560)
compared with Standard (1000 ml; 420e2300- p ¼ 0.01). There were no
signiﬁcant differences in FT, and pre- and post-operative eGFR between the
two groups. Weight and height were distributed equally across both
groups.
Conclusion: Implementation of fusion imaging by a teamwith expertise in
complex endovascular aneurysm repair signiﬁcantly reduces radiation dose
and other performance measures. A further unexpected beneﬁt was signiﬁ-
cant reduction in operative blood loss probably secondary to the signiﬁcantly
shorter procedure time. These ﬁndings suggest that fusion imaging improves
the overall safety proﬁle of FEVAR for both patients and experienced
providers.
